Don’t panic over valsartan recall, patients told

Patients are being warned not to stop taking the valsartan-containing products Dilart and Dilart HCT despite the tablets being subject to a recall because of contamination. The TGA says the angiotensin II antagonist products have been found to contain trace impurities of a possible carcinogen, N-nitrosodiethylamine (NDEA), but the risk is not great enough to ...

Already a member?

Login to keep reading.

© 2021 the limbic